QT IMAGING HOLDINGS, INC. (QTI) Form 10-Q — Aug 12, 2026
QT Imaging Holdings reported Q2 2026 revenue of $7.4 million, up 103% year-over-year, on the sale of 15 Breast Acoustic CT Scanners versus 8 a year ago under minimum order quantities from distributor NXC Imaging; first-half revenue rose 116% to $14.0 million. Net loss for the quarter widened to $11.1 million from $4.0 million, driven primarily by an $8.3 million non-cash loss on the May 2026 modification of the Lynrock Lake term loan, which extended maturity to March 2029 and raised the interest rate from 10% to 12%. The company ended June with $10.9 million in cash, a $67.5 million accumulated deficit, and only $2.2 million of stockholders' equity.
Key figures
- Revenue
- 7435000
- Total Debt
- 11397000
- Revenue Yoy
- 103
- Total Assets
- 30630000
- Cash Position
- 10924000
- Shares Outstanding
- 14636524
- Q2 2025 revenue
- 3659000
- Six month revenue
- 13965000
- Accumulated deficit
- 67500000
- Stockholders equity
- 2246000
- Gross profit q2 2026
- 3060000
- Nxc 2026 moq revenue
- more than $28 million
- Scanners sold q2 2025
- 8
- Scanners sold q2 2026
- 15
- Lynrock warrant shares
- 25313508
- Earnout revenue trigger
- 30000000
- Six month revenue yoy pct
- 116
- Lynrock loan interest rate
- 12% per annum after May 2026 amendment (up from 10%)
- Related party notes payable
- 3895000
- Nxc revenue concentration pct
- 100
- Al naghi moq revenue 2026 2028
- more than $24 million
- Loss on debt extinguishment q2
- 8294000
- Lynrock warrant exercise price
- 0.9639
- May 2026 offering net proceeds
- 8900000
- Shares reserved future issuance
- 44513000
- Gulf medical moq revenue 2026 2028
- more than $51 million
Price after filing
Close on the filing date to close N calendar days later (from $3.01). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.